Skip to content
  • Who We Are
    • About Louis Lehot
    • Key Skills
    • Testimonials
    • Giving Back
  • Resources
    • Vlogs
    • Press
    • Speaking Engagement
    • Startup Resources
    • FAQS
    • Newsletters
    • EBook
  • Services
    • Experience
  • Articles
  • Portfolio
  • Contact Us
  • Who We Are
    • About Louis Lehot
    • Key Skills
    • Testimonials
    • Giving Back
  • Resources
    • Vlogs
    • Press
    • Speaking Engagement
    • Startup Resources
    • FAQS
    • Newsletters
    • EBook
  • Services
    • Experience
  • Articles
  • Portfolio
  • Contact Us
Ask Louis Lehot

Foley Represents NEA as Lead Investor in $200M Series C Round for Abcuro

Foley & Lardner LLP represented New Enterprise Associates (NEA) as the lead investor in the $200 million Series C financing for Abcuro, a clinical-stage biotechnology company. NEA was joined by additional investors Foresite Capital, RA Capital Management, Bain Capital Life Sciences, Redmile Group, Samsara BioCapital, Sanofi Ventures, Pontifax, Mass General Brigham Ventures, New Leaf Ventures, funds managed by abrdn Inc., and funds and accounts managed by BlackRock, Eurofarma Ventures, and Soleus Capital.

Louis Lehot

LLehot@foley.com

+1.650.796.7280

Resources

  • Vlogs
  • Press
  • Speaking Engagement
  • Startup Resources
  • Newsletters
  • EBook

Legal

  • Privacy Policy
  • Accessibility

Subscribe To Our Newsletter

Stay updated by subscribing to our newsletter

Copyright © 2026 Louis Lehot. All rights reserved.

Attorney advertising – prior results do not guarantee a similar outcome. Opinions expressed here are my own and not my law firm.

IMPORTANT DISCLAIMERS